Stem cell factor improves SCID-repopulating activity of human umbilical cord blood-derived hematopoietic stem/progenitor cells in xenotransplanted NOD/SCID mouse model

Bone Marrow Transplantation

Volumn 35, Issue 2, 2005, Pages 137-142

  Zheng, Y ^a   Sun, A ^a   Han, Z C ^a  

^a PEKING UNION MEDICAL COLLEGE   (China)

Author keywords

Engraftment; Hematopoietic stem progenitor cell; NOD SCID mouse; Stem cell factor; Umbilical cord blood

Indexed keywords

GELATINASE A; GELATINASE B; RECOMBINANT STEM CELL FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL MANIPULATION; CELL SPECIFICITY; CONTROLLED STUDY; EX VIVO STUDY; FEMALE; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; IN VIVO STUDY; LEUKOCYTE MIGRATION INHIBITION; LYMPHOCYTE HOMING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCID MOUSE; T LYMPHOCYTE; UMBILICAL CORD BLOOD; XENOTRANSPLANTATION;

ANIMALS; ANTIGENS, CD34; CELL CULTURE TECHNIQUES; CELL MOVEMENT; CORD BLOOD STEM CELL TRANSPLANTATION; GRAFT SURVIVAL; HUMANS; IMMUNOPHENOTYPING; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED NOD; MICE, SCID; MODELS, ANIMAL; STEM CELL FACTOR; TRANSPLANTATION, HETEROLOGOUS;

EID: 13244252349     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1704751     Document Type: Article

References (26)

1. Gluckman E, Rocha V, Boyer-Chammard A et al. Outcome of cord-blood transplantation from related and unrelated donors. N Engl J Med 1997; 337: 373-381.
2. Rubinstein P, Carrier C, Scaradavou A et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med 1998; 339: 1565-1577.
3. Gluckman E. Current status of umbilical cord blood hematopoietic stem cell transplantation. Exp Hematol 2000; 28 1197-1205.
4. Laughlin MJ. Umbilical cord blood for allogeneic transplantation in children and adults. Bone Marrow Transplant 2001; 27: 1-6.
5. Gluckman E, Broxmeyer HA, Auerbach AD et al. Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. N Engl J Med 1989; 321: 1174-1178.
6. Wagner JE, Barker JN, DeFor TE et al. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood 2002; 100: 1611-1618.
7. - cells in ex vivo culture during retroviral transduction without a corresponding increase in SCID repopulating cell (SRC) frequency: dissociation of SRC phenotype and function. Blood 2000; 95: 102-110.
8. + cells. Transfusion 2001; 41: 213-218.
9. Bark JN, Weisdorf DJ, DeFor TE et al. Multiple unit unrelated donor umbilical cord blood transplantation in high risk adults with hematologic malignancies: impact on engraftment and chimerism (abstract). Blood 2002; 100 (Suppl 1): 41a.
10. Vormoor J, Lapidot T, Pflumio F et al. Immature human cord blood progenitors engraft and proliferate to high levels in severe combined immunodeficient mice. Blood 1994; 83: 2489-2497.
11. Ballen KK, Valinski H, Greiner D et al. Variables to predict engraftment of umbilical cord blood into immunodeficient mice: usefulness of the non-obese diabetic-severe combined immunodeficient assay. Br J Haematol 2001; 114: 211-218.
12. +-enriched cells from umbilical cord blood in NOD/LtSz-scid/scid mice. Blood 1997; 90: 85-96.
13. Cashman JD, Lapidot T, Wang JC et al. Kinetic evidence of the regeneration of multilineage hematopoiesis from primitive cells in normal human bone marrow transplanted into immunodeficient mice. Blood 1997; 89: 4307-4316.
14. + cells provides an in vivo model for human megakaryocytopoiesis and platelet production. Blood 2001; 97: 1635-1643.
15. Voermans C, Kooi ML, Rodenhuis S et al. In vitro migratory capacity of CD34+ cells is related to hematopoietic recovery after autologous stem cell transplantation. Blood 2001; 97: 799-804.
16. van Hennik PB, de Koning AE, Ploemacher RE. Seeding efficiency of primitive human hematopoietic cells in nonobese diabetic/severe combined immune deficiency mice: implications for stem cell frequency assessment. Blood 1999; 94: 3055-3061.
17. Cashman JD, Eaves CJ. High marrow seeding efficiency of human lymphomyeloid repopulating cells in irradiated NOD/SCID mice. Blood 2000; 96: 3979-3981.
18. Zheng Y, Watanabe N, Nagamura-Inoue T et al. Ex vivo manipulation of umbilical cord blood-derived hematopoietic stem/progenitor cells with recombinant human stem cell factor can up-regulate levels of homing-essential molecules to increase their transmigratory potential. Exp Hematol 2003; 31: 1237-1246.
19. Srour EF, Jetmore A, Wolber FW et al. Homing, cell cycle kinetics and fate of transplanted hematopoietic stem cells. Leukemia 2001; 15: 1681-1684.
20. + cells transplanted into conditioned NOD/SCID recipients. Blood 2001; 99: 1585-1593.
21. Peled A, Petit I, Kollet O et al. Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. Science 1999; 283: 845-848.
22. + stem and progenitor cells to the bone marrow and spleen of NOD/SCID and NOD/SCID/B2m(null) mice. Blood 2001; 97: 3283-3291.
23. Hart C, Drewel D, Mueller G et al. Expression and function of homing-essential molecules and enhanced in vivo homing ability of human peripheral blood-derived hematopoietic progenitor cells after stimulation with stem cell factor. Stem Cells 2004; 22: 580-589.
24. Nagase H, Woessner Jr JF. Matrix metalloproteinases. J Biol Chem 1999; 274: 21491-21494.
25. + cells and their transmigration through reconstituted basement membrane. Blood 1999; 93: 3379-3390.
26. Lane WJ, Dias S, Hattori K et al. Stromal-derived factor 1-induced megakaryocyte migration and platelet production is dependent on matrix metalloproteinases. Blood 2000; 96: 4152-4159.